Results 121 to 130 of about 767,219 (291)
Malignant Mesothelioma Clinical Trial Combines Immunotherapy Drugs [PDF]
Monica Sheila Chatwal, Tawee Tanvetyanon
openalex +1 more source
Table11_Hypoxic Characteristic Genes Predict Response to Immunotherapy for Urothelial Carcinoma.XLSX
Shuo Hong (11755601) +7 more
openalex +2 more sources
Engineering magnetic nano-manipulators for boosting cancer immunotherapy [PDF]
Bin Yan +10 more
openalex +1 more source
ABSTRACT Objective The optimal treatment for neurosarcoidosis myelitis is uncertain. We characterize incident neurosarcoidosis myelitis and assess treatment response by MRI and clinical scales. Methods Incident probable or definite neurosarcoidosis myelitis in adults was retrospectively identified from 13 academic medical centers.
Giovanna S. Manzano +39 more
wiley +1 more source
Epicutaneous Immunotherapy Induces Epigenetic Changes In Sensitized Mice [PDF]
Lucie Mondoulet +7 more
openalex +1 more source
INF2‐Related Charcot–Marie–Tooth Disease in a Japanese Cohort: Genetic and Clinical Insights
ABSTRACT Background INF2 mutations cause focal segmental glomerulosclerosis (FSGS) and Charcot–Marie–Tooth disease (CMT). Accurate genetic diagnosis is critical, as INF2‐related FSGS is typically resistant to immunotherapy yet rarely recurs after transplantation, and its associated neuropathy can mimic treatable immune‐mediated disorders such as ...
Chikashi Yano +27 more
wiley +1 more source
Decreased Serum 5‐HT: Clinical Correlates and Regulatory Role in NMJ of MG
ABSTRACT Objective Although 5‐Hydroxytryptamine (5‐HT) indirectly stimulates muscle contraction and participates in regulating Acetylcholine receptor (AChR) cluster homeostasis in cellular, animal, and clinical studies, evidence regarding its potential to modulate muscle contraction in myasthenia gravis (MG) remains limited.
Xinru Shen +18 more
wiley +1 more source

